326 related articles for article (PubMed ID: 16129903)
21. IL-23/IL-17A axis correlates with the nitric oxide pathway in inflammatory bowel disease: immunomodulatory effect of retinoic acid.
Rafa H; Saoula H; Belkhelfa M; Medjeber O; Soufli I; Toumi R; de Launoit Y; Moralès O; Nakmouche M; Delhem N; Touil-Boukoffa C
J Interferon Cytokine Res; 2013 Jul; 33(7):355-68. PubMed ID: 23472658
[TBL] [Abstract][Full Text] [Related]
22. Homeostatic (IL-7) and effector (IL-17) cytokines as distinct but complementary target for an optimal therapeutic strategy in inflammatory bowel disease.
Kanai T; Nemoto Y; Kamada N; Totsuka T; Hisamatsu T; Watanabe M; Hibi T
Curr Opin Gastroenterol; 2009 Jul; 25(4):306-13. PubMed ID: 19448533
[TBL] [Abstract][Full Text] [Related]
23. Local blockade of IL-6R signaling induces lung CD4+ T cell apoptosis in a murine model of asthma via regulatory T cells.
Finotto S; Eigenbrod T; Karwot R; Boross I; Doganci A; Ito H; Nishimoto N; Yoshizaki K; Kishimoto T; Rose-John S; Galle PR; Neurath MF
Int Immunol; 2007 Jun; 19(6):685-93. PubMed ID: 17496315
[TBL] [Abstract][Full Text] [Related]
24. The regenerative activity of interleukin-6.
Galun E; Rose-John S
Methods Mol Biol; 2013; 982():59-77. PubMed ID: 23456862
[TBL] [Abstract][Full Text] [Related]
25. First case report of exacerbated ulcerative colitis after anti-interleukin-6R salvage therapy.
Atreya R; Billmeier U; Rath T; Mudter J; Vieth M; Neumann H; Neurath MF
World J Gastroenterol; 2015 Dec; 21(45):12963-9. PubMed ID: 26668517
[TBL] [Abstract][Full Text] [Related]
26. Modulation of Pro-Inflammatory IL-6 Trans-Signaling Axis by Splice Switching Oligonucleotides as a Therapeutic Modality in Inflammation.
Gupta D; Orehek S; Turunen J; O'Donovan L; Gait MJ; El-Andaloussi S; Wood MJA
Cells; 2023 Sep; 12(18):. PubMed ID: 37759507
[TBL] [Abstract][Full Text] [Related]
27. Signaling molecules: the pathogenic role of the IL-6/STAT-3 trans signaling pathway in intestinal inflammation and in colonic cancer.
Atreya R; Neurath MF
Curr Drug Targets; 2008 May; 9(5):369-74. PubMed ID: 18473764
[TBL] [Abstract][Full Text] [Related]
28. The pentacyclic triterpene Lupeol switches M1 macrophages to M2 and ameliorates experimental inflammatory bowel disease.
Zhu Y; Li X; Chen J; Chen T; Shi Z; Lei M; Zhang Y; Bai P; Li Y; Fei X
Int Immunopharmacol; 2016 Jan; 30():74-84. PubMed ID: 26655877
[TBL] [Abstract][Full Text] [Related]
29. The role of adipose tissue-associated macrophages and T lymphocytes in the pathogenesis of inflammatory bowel disease.
Jung SH; Saxena A; Kaur K; Fletcher E; Ponemone V; Nottingham JM; Sheppe JA; Petroni M; Greene J; Graves K; Baliga MS; Fayad R
Cytokine; 2013 Feb; 61(2):459-68. PubMed ID: 23245845
[TBL] [Abstract][Full Text] [Related]
30. Profile of soluble cytokine receptors in Crohn's disease.
Gustot T; Lemmers A; Louis E; Nicaise C; Quertinmont E; Belaiche J; Roland S; Van Gossum A; Devière J; Franchimont D
Gut; 2005 Apr; 54(4):488-95. PubMed ID: 15753533
[TBL] [Abstract][Full Text] [Related]
31. Interleukin-6 trans-signalling in chronic inflammation and cancer.
Scheller J; Ohnesorge N; Rose-John S
Scand J Immunol; 2006 May; 63(5):321-9. PubMed ID: 16640655
[TBL] [Abstract][Full Text] [Related]
32. Lamina propria and circulating interleukin-6 in newly diagnosed pediatric inflammatory bowel disease patients.
Brown KA; Back SJ; Ruchelli ED; Markowitz J; Mascarenhas M; Verma R; Piccoli DA; Baldassano RN
Am J Gastroenterol; 2002 Oct; 97(10):2603-8. PubMed ID: 12385446
[TBL] [Abstract][Full Text] [Related]
33. In situ expression of interleukin-10 in noninflamed human gut and in inflammatory bowel disease.
Autschbach F; Braunstein J; Helmke B; Zuna I; Schürmann G; Niemir ZI; Wallich R; Otto HF; Meuer SC
Am J Pathol; 1998 Jul; 153(1):121-30. PubMed ID: 9665472
[TBL] [Abstract][Full Text] [Related]
34. Interleukin-6/soluble interleukin-6 receptor signaling attenuates proliferation and invasion, and induces morphological changes of a newly established pleomorphic malignant fibrous histiocytoma cell line.
Nakanishi H; Yoshioka K; Joyama S; Araki N; Myoui A; Ishiguro S; Ueda T; Yoshikawa H; Itoh K
Am J Pathol; 2004 Aug; 165(2):471-80. PubMed ID: 15277221
[TBL] [Abstract][Full Text] [Related]
35. Lamina propria and circulating interleukin-8 in newly and previously diagnosed pediatric inflammatory bowel disease patients.
Reddy KP; Markowitz JE; Ruchelli ED; Baldassano RN; Brown KA
Dig Dis Sci; 2007 Feb; 52(2):365-72. PubMed ID: 17219072
[TBL] [Abstract][Full Text] [Related]
36. Sonic hedgehog inhibitors prevent colitis-associated cancer via orchestrated mechanisms of IL-6/gp130 inhibition, 15-PGDH induction, Bcl-2 abrogation, and tumorsphere inhibition.
Kangwan N; Kim YJ; Han YM; Jeong M; Park JM; Go EJ; Hahm KB
Oncotarget; 2016 Feb; 7(7):7667-82. PubMed ID: 26716648
[TBL] [Abstract][Full Text] [Related]
37. [The role of IL-6/sIL-6R complex and its natural inhibitor sgp130 in modulation of inflammatory process].
Augustyniak D; Majkowska-Skrobek G; Basiewicz-Worsztynowicz B; Jankowski A
Postepy Biochem; 2006; 52(2):194-203. PubMed ID: 17078509
[TBL] [Abstract][Full Text] [Related]
38. Epstein-Barr virus (EBV) infection and expression of the interleukin-12 family member EBV-induced gene 3 (EBI3) in chronic inflammatory bowel disease.
Gehlert T; Devergne O; Niedobitek G
J Med Virol; 2004 Jul; 73(3):432-8. PubMed ID: 15170639
[TBL] [Abstract][Full Text] [Related]
39. Dietary cocoa inhibits colitis associated cancer: a crucial involvement of the IL-6/STAT3 pathway.
Saadatdoust Z; Pandurangan AK; Ananda Sadagopan SK; Mohd Esa N; Ismail A; Mustafa MR
J Nutr Biochem; 2015 Dec; 26(12):1547-58. PubMed ID: 26355019
[TBL] [Abstract][Full Text] [Related]
40. Interleukin-6 and its receptor: from bench to bedside.
Scheller J; Rose-John S
Med Microbiol Immunol; 2006 Dec; 195(4):173-83. PubMed ID: 16741736
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
